Your browser doesn't support javascript.
loading
Daily Onset of Light and Darkness Differentially Controls Hematopoietic Stem Cell Differentiation and Maintenance.
Golan, Karin; Kumari, Anju; Kollet, Orit; Khatib-Massalha, Eman; Subramaniam, Mohana Devi; Ferreira, Zulma S; Avemaria, Francesca; Rzeszotek, Sylwia; García-García, Andrés; Xie, Stephanie; Flores-Figueroa, Eugenia; Gur-Cohen, Shiri; Itkin, Tomer; Ludin-Tal, Aya; Massalha, Hassan; Bernshtein, Biana; Ciechanowicz, Andrzej K; Brandis, Alexander; Mehlman, Tevie; Bhattacharya, Suditi; Bertagna, Mayla; Cheng, Hui; Petrovich-Kopitman, Ekaterina; Janus, Tomasz; Kaushansky, Nathali; Cheng, Tao; Sagi, Irit; Ratajczak, Mariusz Z; Méndez-Ferrer, Simón; Dick, John E; Markus, Regina P; Lapidot, Tsvee.
Afiliação
  • Golan K; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Kumari A; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Kollet O; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Khatib-Massalha E; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Subramaniam MD; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Ferreira ZS; Physiology Department, University of São Paulo, São Paulo, Brazil.
  • Avemaria F; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Rzeszotek S; Physiology Department, Pomeranian Medical University, Szczecin, Poland.
  • García-García A; Haematology Department, University of Cambridge, Cambridge, UK.
  • Xie S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Flores-Figueroa E; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada; Oncology Research Unit, Oncology Hospital, National Medical Center Century XXI, IMSS, Mexico City, Mexico.
  • Gur-Cohen S; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Itkin T; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Ludin-Tal A; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Massalha H; Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Bernshtein B; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Ciechanowicz AK; Regenerative Medicine Department, University of Warsaw, Warsaw, Poland.
  • Brandis A; Life Science Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Mehlman T; Life Science Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Bhattacharya S; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Bertagna M; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Cheng H; Immunology Department, Weizmann Institute of Science, Rehovot, Israel; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Petrovich-Kopitman E; Life Science Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
  • Janus T; Forensic Medicine Department, Pomeranian Medical University, Szczecin, Poland.
  • Kaushansky N; Immunology Department, Weizmann Institute of Science, Rehovot, Israel.
  • Cheng T; State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Sagi I; Biological Regulation Department, Weizmann Institute of Science, Rehovot, Israel.
  • Ratajczak MZ; Stem Cell Institute, University of Louisville, Louisville, KY, USA.
  • Méndez-Ferrer S; Haematology Department, University of Cambridge, Cambridge, UK.
  • Dick JE; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Markus RP; Physiology Department, University of São Paulo, São Paulo, Brazil.
  • Lapidot T; Immunology Department, Weizmann Institute of Science, Rehovot, Israel. Electronic address: tsvee.lapidot@weizmann.ac.il.
Cell Stem Cell ; 23(4): 572-585.e7, 2018 10 04.
Article em En | MEDLINE | ID: mdl-30174297
ABSTRACT
Hematopoietic stem and progenitor cells (HSPCs) tightly couple maintenance of the bone marrow (BM) reservoir, including undifferentiated long-term repopulating hematopoietic stem cells (LT-HSCs), with intensive daily production of mature leukocytes and blood replenishment. We found two daily peaks of BM HSPC activity that are initiated by onset of light and darkness providing this coupling. Both peaks follow transient elevation of BM norepinephrine and TNF secretion, which temporarily increase HSPC reactive oxygen species (ROS) levels. Light-induced norepinephrine and TNF secretion augments HSPC differentiation and increases vascular permeability to replenish the blood. In contrast, darkness-induced TNF increases melatonin secretion to drive renewal of HSPCs and LT-HSC potential through modulating surface CD150 and c-Kit expression, increasing COX-2/αSMA+ macrophages, diminishing vascular permeability, and reducing HSPC ROS levels. These findings reveal that light- and darkness-induced daily bursts of norepinephrine, TNF, and melatonin within the BM are essential for synchronized mature blood cell production and HSPC pool repopulation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Diferenciação Celular / Escuridão / Luz Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células-Tronco Hematopoéticas / Diferenciação Celular / Escuridão / Luz Limite: Animals Idioma: En Ano de publicação: 2018 Tipo de documento: Article